These data further strengthen our confidence in Reblozyl’s potential to become a meaningful option for this important, underserved patient population around the world.â€... Jun 11
Molnupiravir, the antiviral drug was initially developed for the treatment of influenza and is repurposed to completely suppress the COVID virus transmission within 24 hours.... Jun 11
... Jun 11
-Advertisements-